FDA NDC Directory · JSON-LD · Markdown

MnB rLP2086 subfamily B protein

NDC 68594-028 · VACCINE · SUSPENSION

Labeler / ManufacturerBoehringer Ingelheim RCV GmbH & Co KG
Marketing categoryDRUG FOR FURTHER PROCESSING
Dosage form / routeSUSPENSION
Active ingredientsNEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT LP2086 B01 PROTEIN VARIANT ANTIGEN (.06 mg/.06mg)
Marketing started20141029
Package count1

External sources

Source: openFDA. Public-domain (CC0).